Carregant...
COVID-19: a potential driver of immune-mediated breast cancer recurrence?
Severe coronavirus disease 2019 (COVID-19) causes a hyperactivation of immune cells, resulting in lung inflammation. Recent studies showed that COVID-19 induces the production of factors previously implicated in the reawakening of dormant breast cancer cells such as neutrophil extracellular traps (N...
Guardat en:
| Publicat a: | Breast Cancer Res |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7598231/ https://ncbi.nlm.nih.gov/pubmed/33126915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01360-0 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|